메뉴 건너뛰기




Volumn 68, Issue 3, 2000, Pages 325-327

Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients [3]

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

EID: 0034479748     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (30)

References (15)
  • 3
    • 0001903141 scopus 로고
    • Biologic therapy with TNF: Preclinical studies
    • Biology Therapy of Cancer, 2nd edn. De Vita, V. T., Jr., Hellman, S. and Rosenberg, S. A., eds. New York: J. P. Lippincott Co.
    • (1995) , pp. 295-327
    • Fiers, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.